A
ADMA Biologics, Inc. (ADMA)
NGM – Real vaqt narxi. Valyuta: USD
8.41
+0.53 (6.73%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.62
+0.21 (2.50%)
Bozordan keyin: May 12, 2026, 7:58 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
8.41
+0.53 (6.73%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.62
+0.21 (2.50%)
Bozordan keyin: May 12, 2026, 7:58 PM EDT
This stock has a consensus price target of $24.00 based on the ratings of 5 analysts. The high is $32.00 and the low is $18.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 18 | $ 24 | $ 32 |
| O’zgarish | 120.32% | 193.76% | 291.68% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-07 | 120.32% | Canaccord Genuity | $21 → $18 | Maintains | Buy |
| 2026-05-07 | 144.8% | Mizuho | $24 → $20 | Maintains | Outperform |
| 2026-04-21 | 157.04% | Canaccord Genuity | $21 | Initiates Coverage On | Buy |
| 2026-04-13 | 193.76% | Mizuho | $30 → $24 | Maintains | Outperform |
| 2026-03-26 | — | Cantor Fitzgerald | — | Downgrades | Overweight → Neutral |